C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C12P 21/06 (2006.01) C40B 30/04 (2006.01) G01N 33/53 (2006.01) G01N 33/567 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2664178
Human VIPRl genes are identified as modulators of the E2F/RB pathway, and thus are therapeutic targets for disorders associated with defective E2F/RB function. Methods for identifying modulators of E2F/RB, comprising screening for agents that modulate the activity of VIPRl are provided.
Les gènes VIPR1 humains sont identifiés comme modulateurs de la voie E2F/RB et sont ainsi des cibles thérapeutiques pour des troubles associés à une fonction E2F/RB défectueuse. L'invention concerne des procédés permettant d'identifier des modulateurs de E2F/RB comportant le criblage d'agents qui modulent l'activité de VIPR1.
Edgar Kyle A.
Ferguson Kimberly Carr
Nicoll Monique
Winter Christopher G.
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Vipr1s as modifiers of the e2f/rb pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vipr1s as modifiers of the e2f/rb pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vipr1s as modifiers of the e2f/rb pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1894923